An elderly lady with symptomatic diastolic Hf post myomectomy for HCM came to ask why was she was given anti diabetic meds, while her sugars are normal. Took me nearly15-20 minutes to explain to her role of SGLT2inhibitors diastolic heart failure.

A CME on ‘Interventional Cardiology’ was successfully organised by Max Hospital, Shalimar Bagh jointly with ICSR on 23rd Oct.21, Sat at Hotel Crowne Plaza, Rohini, Delhi. #interventionalcardiology #DES #ComplexPCI #SGLT2inhibitors #zerocantrstPCI #cardiologistbeyondcoronary

The Role of #SGLT2Inhibitors on #HeartFailure Outcomes in Nondiabetic Patients:
A Systematic Review and Meta-Analysis of RCTs
journals.lww.com/cardiovascular…
#2023review #cardiology #CardioTwitter #CardioEd #openaccess

تم نشر بحث عبارة عن مراجعة منهجية وتحليلة لعدد من الدراسات المهمة اظهرت ان الادوية من مجموعة SGLT2inhibitors مثل فورسيغا وجاردينس وانفوكانا خفض من خطر تدهور وظائف الكلى والفشل الكلوى والغسيل الكلوى او الوفاة بإذن الله لدى المرضى المصابين بداء السكر النوع٢.لا بد اخذ ذلك في الحسبان

نشر بحث عام٢٠١٩م عبارة عن مراجعة منهجيةوتحليلةلعدد من الدراسات المهمة اظهرت ان الادوية من مجموعة (SGLT2inhibitors)مثل فورسيغا وجاردينس وانفوكاناخفض من خطر تدهور وظائف الكلى والفشل الكلوى والغسيل الكلوى او الوفاة بإذن الله لدى المرضى داء السكر النوع٢.هذا بالإضافةللفوائد على القلب.

Lets step into the new era of SGLT2 inhibitors!! #sglt2inhibitors

'Six Simple Steps for SGLT2 Inhibitors!'

Thank you Nephrology Education Collective Internship Matthew Sparks, MD Michelle Lim Sophia Ambruso Dominique Tomacruz, MD Corina Teodosiu 🕊️ 🇺🇦 & Team beanpod!

[✅] High-yield Endo SGD with Dr. Wagan! #EuglycemicDKA #SGLT2inhibitors Aaron Yumang

Mitigation strategies vs side effects of SGLT2inhibitors and GLP-1 Receptor agonists
#ISNWCN 🇲🇾 #Nephpearls

From Pump to Periphery: the Graded Benefit of #SGLT2Inhibitors in #HFrEF and Progressive Vascular Disease : #Editorial Ashish Correa Journal of Cardiac Failure
onlinejcf.com/article/S1071-…

Had fun presenting grand rounds on #SGLT2Inhibitors in #Heart #Failure and discussing the EMPEROR-Reduced and DAPA-HF trials! As a #golf nerd, the “Sweet Spot” of HFrEF makes more sense to me 😊UC San Diego Cardiology Fellows UCSD Internal Medicine Residency Eric Adler Marcus Anthony Urey MD Clyde Yancy, MD, MSc Larry A. Allen, MD Lisa LeMond

Do SGLT2 inhibitors play a key role in CKD management even in the absence of #diabetes ? Learn more from this Translational Perspective of the DAPA-CKD trial in this issue of #JACCBTS : bit.ly/3otGoni #CKD #SGLT2inhibitors

CREDENCE Trial #VisualAbstract - The first VA for our upcoming cardiology trials app! #SGLT2inhibitors #type2diabetes #ISNWCN2019 Dr Anastasia Mihailidou FAHA FCSANZ FESC Philip Newland-Jones Matthew Sparks, MD Jared Cook, MD Sanjeev Nair Susan Quaggin Nathaniel Reisinger Binaya Basyal Vlado Perkovic Juan Carlos Q Velez

أوصت الجمعيةالأمريكيةلأمراض السكر وبناء على دراسات موثقة بإستخدام الأدوية من مجموعة(SGLT2inhibitors)⬇️

جاردينس فورسيغا انفوكانا لمرضى داء السكر النوع٢ في حالة عدم قدرة التحكم بالسكر مع علاج القلوكوفاج.

لقدرتها على⬇️
❇️خفض معدل السكر التراكمي
❇️خفض خطر الفشل الكلوى وأمراض القلب

Dr Niamh Murphy giving an updated overview of Heart Failure.
Most important thing to identify EF if BNP elevated to identify phenotype - echo
HF with mildy reduced EF, similar treatment for HFrEF
4 pillars of treatment
ACEi/ARNI, BB, MRA, SGLT2inhibitors

Day2 of #ENDO2022
Stop by at my poster booth 291. I am presenting a case of Fournier’s Gangrene in a diabetic patient taking dapagliflozin Endocrine Society #EndoTwitter #diabetes #SGLT2inhibitors

SGLT2inhibitors in the 🏥 How sweet! 🫶🏼🫀🫶🏼
#AHA23 🫀
Josh J Park, PharmD Purnata Tyler D Webster, MD, FACC Greg Katz Albert Jung AHA Science NYU Grossman School of Medicine NYU Langone Health NYU Langone Hospital—Long Island

Phenomenal presentation by the one and only Dr. Deepak L. Bhatt

Grand Rounds Cedars-Sinai
#CardioTwitter #Cardiology #SGLT2inhibitors #diabetes

📢CardioNerds #HeartSuccess series continues❣️

🎤 149. #SGLT2Inhibitors – Under-Promised & Over-Delivered with #MiltonPackerMD 🎙

👉 #EMPERORpreservedTRIAL 👈

🔗 cardionerds.com/149-the-evolut…

🔗Heart Success Series: cardionerds.com/heart-failure/

Late Breaking clinical trials moderated by ⁦Eric D. Peterson⁩ and ⁦AnnabelleVolgman MD⁩ The audience feels comfortable prescribing #SGLT2inhibitors ⁦RUSH⁩ ⁦Kim Williams⁩

In the 1st #SGLT2inhibitors #CV outcome trial to evaluate #type2diabetes patients stratified by EF, #dapagliflozin reduced hospitalizations for #HF in patients with and without #HF rEF, & reduced #CV death & mortality in #HF rEF ow.ly/7gbM50us1ZM #AHAJournals